Rethinking Cardiovascular Risk: Remnant Cholesterol vs LDL Cholesterol
Mobina Imannezhad, MSc in Clinical Nutrition at Mashhad University of Medical Sciences, posted on LinkedIn:
”Excited to share our latest article, ‘Emerging importance of remnant cholesterol compared with low-density lipoprotein cholesterol in cardiovascular risk assessment.’
The study yielded significant findings. Elevated levels of remnant cholesterol (RC) and LDL are robust predictors of Cardiovascular Disease (CVD) and Coronary Artery Disease (CAD). Furthermore, the combination of higher RC and lower LDL levels provides enhanced risk prediction, underscoring the critical role of RC in CVD risk assessment.
I extend my sincere appreciation to our collaborative team for their invaluable support and commitment.”
Read the full article here.
Title: Emerging importance of remnant cholesterol compared with low-density lipoprotein cholesterol in cardiovascular risk assessment
Authors: Farzam Kamrani, Mobina Imannezhad, Ali Rezaee, Susan Darroudi, Aida Yavari Kondori, Sara Sadatian, Bahram Shahri, Habibollah Esmaily, AliReza Heidari Bakavoli, Majid Ghayour-Mobarhan, Leila Bigdelu, Mohsen Moohebati

Stay updated with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership